Roy, P., Banik, D., Chowdhury, F., & Bakar Siddique, M. A. (2026). Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. World Journal of Oncology, 17(5), 599-613. https://doi.org/10.14740/wjon2842